A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Going for broke: how universities can deliver on their economic potential
7 August 2012
By Stephen Caddick, Vice-Provost (Enterprise) at UCL
The UK needs an economic game changer and we are incredibly fortunate to have a platform from which we can launch it – our universities.
Read the full article at www.guardian.co.uk